Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/10/ge-healthcare-jumps-6-after-earnings-beat-and-outlook-rises.webp

GE HealthCare Climbs 8% After Earnings Beat And Outlook Raise

TIM BOHEN•UPDATED OCT. 28, 2026, 2:44 PM ET
Reviewed by Ben Sturgilland Fact-checked by Jeff Zananiri

GE HealthCare rose 8% after earnings topped expectations and a higher outlook signaled stronger profit and sales ahead.

GEHC Candlestick Chart

Get Free Alerts

Why GE HealthCare Stock Jumped 8% Today

GE HealthCare Technologies Inc. (NASDAQ: GEHC) is up 8% at $76.93 this afternoon after reporting stronger-than-expected quarterly results and raising its outlook. Adjusted earnings per share, profit per share with certain costs removed, topped expectations. Shares reached the $80 level before regular trading began.

What GE HealthCare Technologies Inc. Does

GE HealthCare sells medical imaging systems and diagnostic tools used by hospitals and clinics. Those products help care teams examine patients and find signs of disease. Sales depend in part on hospitals continuing to buy and use its equipment.

GE HealthCare Raised Its Outlook

Management pointed to broad customer demand and better execution as drivers of sales growth and wider profit margins, meaning more profit from each sales dollar. It lifted its annual adjusted earnings forecast and increased its sales growth outlook. That gives investors reason to expect recent business gains to continue beyond the reported quarter.

GE HealthCare Volume Reaches about 5.7 million shares

Trading volume reached about 5.7 million shares, brisker than usual for this hour. The price move is also unusual for this stock: the last daily move this large was sixty-four sessions ago.

Quick Financial Overview

GE HealthCare is a profitable large-cap, meaning its shares have a high total market value. Its shares are valued at $34.75B, and its financial snapshot lists $2.08B in cash and cash equivalents, meaning cash the company can spend, as of June 30, 2026.

GE HealthCare Revenue Growth

Sales rose from a year earlier across the company’s businesses. Revenue is money brought in before expenses, so continued sales growth can support profit if costs stay controlled. The increase shows customer demand reached reported sales, rather than remaining unfilled orders.

GE HealthCare Patient Care Supply Improvements

Management said its patient care business resolved earlier supply challenges and delivered more outstanding customer orders. Turning those orders into deliveries helps the company collect revenue from business it has already won.

Get Free Alerts

GE HealthCare Stock Rebounds From the $65 level

GE HealthCare has climbed from that area over the past month, extending a recovery that began before today’s report. Its one-year performance remains down 2%, so the recent climb has not erased the longer decline.

Trading Perspective

The next level above is the $90 level, the high from the past year. The opening gap, the jump between the prior close and today’s open, has its floor at the $70 level. Falling back there would erase the initial jump.

Get Free Alerts

Conclusion

The next quarterly earnings report will test whether hospital demand keeps turning into deliveries without renewed supply delays. Continued progress would support the recovery, while fresh delays would weaken that case. The company has not provided a date for that report here.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders